Cargando…
Increased expression of the retinoic acid-metabolizing enzyme CYP26A1 during the progression of cervical squamous neoplasia and head and neck cancer
BACKGROUND: Retinoic acid (RA) is a critical regulator of cell differentiation, proliferation, and apoptosis in various cell types. Recently, the RA-metabolizing enzyme CYP26A1 (cytochrome P450, family 26, subfamily A, polypeptide 1) has been shown to have an oncogenic function in breast carcinogene...
Autores principales: | Osanai, Makoto, Lee, Gang-Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4198729/ https://www.ncbi.nlm.nih.gov/pubmed/25294402 http://dx.doi.org/10.1186/1756-0500-7-697 |
Ejemplares similares
-
Regulating Retinoic Acid Availability during Development and Regeneration: The Role of the CYP26 Enzymes
por: Roberts, Catherine
Publicado: (2020) -
Polymorphism in the Retinoic Acid Metabolizing Enzyme CYP26B1 and the Development of Crohn’s Disease
por: Fransén, Karin, et al.
Publicado: (2013) -
Retinoic acid catabolizing enzyme CYP26C1 is a genetic modifier in SHOX deficiency
por: Montalbano, Antonino, et al.
Publicado: (2016) -
The Retinoic Acid-Metabolizing Enzyme Cyp26b1 Regulates CD4 T Cell Differentiation and Function
por: Chenery, Alistair, et al.
Publicado: (2013) -
Expression of the retinoic acid catabolic enzyme CYP26B1 in the human brain to maintain signaling homeostasis
por: Stoney, Patrick N., et al.
Publicado: (2015)